| Saham Diterbitkan | 112,873,552 shares |
| Saham Orang Dalam | 161,383,910 shares |
| Jumlah Orang Dalam | 17 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mendapati syarikat dibeli oleh orang dalam korporat.
Ia adalah hasil daripada model kuantitatif berbilang faktor yang canggih yang mengenal pasti syarikat dengan tahap pengumpulan orang dalam yang paling tinggi. Model pemarkahan menggunakan gabungan bilangan bersih orang dalam yang membeli 90 hari sebelumnya, jumlah saham yang dibeli sebagai peratusan saham beredar, dan jumlah saham yang dimiliki oleh orang dalam. Nombor ini berjulat dari 0 hingga 100, dengan nombor yang lebih tinggi menunjukkan tahap pengumpulan yang lebih tinggi kepada rakannya, dan 50 adalah purata.
Kekerapan Kemas Kini: Harian
Skor Sentimen Pegawai
Skor Sentimen Pegawai mendapati syarikat dibeli oleh Pegawai Korporat.
Mengikut definisi Pegawai Korporat ialah Orang Dalam Korporat, tetapi tidak seperti beberapa Orang Dalam yang lain (10% Pemegang Saham dan Ahli Lembaga), Pegawai bekerja untuk syarikat tersebut setiap hari, dan mereka menggunakan wang mereka sendiri semasa berdagang . (10% Pemegang Saham dan Ahli Lembaga Pengarah selalunya pengurus dana yang menguruskan wang orang lain.) Oleh itu, dagangan orang dalam yang dibuat oleh Pegawai adalah lebih penting dan harus dilayan dengan sewajarnya.
Seperti Skor Sentimen Orang Dalam, Skor Sentimen Pegawai adalah hasil daripada model kuantitatif berbilang faktor yang canggih yang mengenal pasti syarikat yang mempunyai tahap pengumpulan pegawai tertinggi.
Kekerapan Kemas Kini: Harian
Metrik Orang Dalam Utama
Kad ini menunjukkan bagaimana kedudukan syarikat mengikut pelbagai metrik orang dalam. Kedudukan persentil menunjukkan cara syarikat ini dibandingkan dengan syarikat lain di pasaran AS. Kedudukan yang lebih tinggi menunjukkan keadaan yang lebih baik.
Sebagai contoh, adalah diterima umum bahawa pembelian orang dalam ialah penunjuk positif, jadi syarikat yang mempunyai lebih banyak pembelian orang dalam akan mendapat kedudukan lebih tinggi daripada syarikat yang kurang pembelian orang dalam (atau malah jualan orang dalam).
Peratusan Saham Beredar yang Dibeli oleh Orang Dalam (Kedudukan)
0.000 %( )
8841 out of 11224Peratusan Saham Beredar yang Dibeli oleh Orang Dalam ialah jumlah bilangan saham yang dibeli oleh orang dalam tolak jumlah bilangan saham yang dijual oleh orang dalam dalam tempoh 90 hari terakhir, dibahagikan dengan jumlah saham beredar dan didarab dengan 100.
Carta Dagangan Dalaman
Vaxxinity, Inc. dagangan dalaman ditunjukkan dalam carta berikut. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Secara umumnya adalah menyalahi undang-undang bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat material dan bukan awam. Ini tidak bermakna haram untuk mereka membuat sebarang perdagangan dalam syarikat mereka sendiri. Walau bagaimanapun, mereka mesti melaporkan semua dagangan kepada SEC melalui Borang 4.
Senarai Orang Dalam dan Metrik Keberuntungan
Jadual ini menunjukkan senarai orang dalam yang diketahui dan dijana secara automatik daripada pemfailan yang didedahkan kepada SEC. Sebagai tambahan kepada nama, gelaran terkini dan pengarah, pegawai, atau 10% jawatan pemilik, kami menyediakan pegangan yang didedahkan terkini. Selain itu, apabila boleh, kami menyediakan sejarah prestasi perdagangan untuk orang dalam. Sejarah prestasi perdagangan ialah purata wajaran prestasi transaksi pembelian pasaran terbuka sebenar yang dibuat oleh orang dalam. Untuk mendapatkan maklumat lanjut tentang cara ini dikira, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang dalam | Purata Keuntungan (%) | Saham Dimiliki |
Berpecah Dilaraskan |
|---|---|---|---|
| Gregory R Blatt Director - [D] | 76,923 | 76,923 | |
| James Chui Director - [D] | 14,000 | 14,000 | |
| Peter Diamandis Director - [D] | 2,019,880 | 2,019,880 | |
| Martin Doran See Remarks - [O] | 22,688 | 22,688 | |
| Farshad Guirakhoo (Former) Chief Scientific Off. - [O] | 68,645 | 68,645 |
| Orang dalam | Purata Keuntungan (%) | Saham Dimiliki |
Berpecah Dilaraskan |
|---|---|---|---|
| George R Hornig | 67,953 | ||
|
Mei Mei Hu
See Remarks, Director, 10% Owner -
[D]
[O]
|
51,737,344 | 51,737,344 | |
| Landon E Ogilvie Director - [D] | 32,850 | 32,850 | |
| Ulo Palm Chief Medical Officer - [O] | 450 | 450 | |
| Molina Rene Paula | 96,153 | ||
| Jason Pesile | 51,225 |
| Orang dalam | Purata Keuntungan (%) | Saham Dimiliki |
Berpecah Dilaraskan |
|---|---|---|---|
| Peter Powchik Director - [D] | 225,858 | 225,858 | |
|
Prime Movers Lab Fund I LP
10% Owner -
|
3,594,122 | 3,594,122 | |
|
Lou Reese
Executive Chairman, Director, 10% Owner -
[D]
[O]
|
51,737,344 | 51,737,344 | |
|
Dakin Sloss
10% Owner -
|
9,738,192 | 3,594,122 | |
| James Alan Smith Director - [D] | 116,462 | 116,462 | |
|
United Biomedical Inc
10% Owner -
|
51,737,344 | 51,737,344 |
Report errors via our new Insider Auditing Tool
Rekod Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam VAXX / Vaxxinity, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras pecah.
Rekod Jejak Jualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam VAXX / Vaxxinity, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras pecah.
Sejarah Transaksi
Klik ikon pautan untuk melihat sejarah transaksi penuh. Transaksi yang dilaporkan sebagai sebahagian daripada pelan dagangan automatik 10b5-1 akan mempunyai X dalam lajur bertanda 10b-5.
| Fail Tarikh |
Dagangan Tarikh |
Borang | Orang dalam | Simbol Saham | Nama Sekuriti | Kod | Langsung | Harga Pelaksanaan |
Harga Unit |
Unit Berubah |
Nilai Berubah (1K) |
Baki Opsyen |
Baki Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Class A common stock | I | 1.6700 | -10,349 | -17 | 3,594,122 | ||||
| 2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A common stock | I | 1.6700 | -4,217 | -7 | 1,464,578 | ||||
| 2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 1.6700 | -2,395 | -4 | 831,658 | ||||
| 2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A common stock | D | 1.6700 | -25,089 | -42 | 8,713,663 | ||||
| 2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A common stock | I | 1.6700 | -5,911 | -10 | 2,053,079 | ||||
| 2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Class A common stock | I | 1.7872 | -8,378 | -15 | 3,604,471 | ||||
| 2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A common stock | I | 1.7872 | -3,413 | -6 | 1,468,795 | ||||
| 2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 1.7872 | -1,939 | -3 | 834,053 | ||||
| 2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 1.7872 | -20,312 | -36 | 8,738,752 | ||||
| 2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 1.7872 | -4,786 | -9 | 2,058,990 | ||||
| 2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Class A Common Stock | I | 1.8823 | -2,189 | -4 | 3,612,849 | ||||
| 2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 1.8823 | -892 | -2 | 1,472,208 | ||||
| 2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 1.8823 | -507 | -1 | 835,992 | ||||
| 2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 1.8823 | -5,308 | -10 | 8,759,064 | ||||
| 2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 1.8823 | -1,251 | -2 | 2,063,776 | ||||
| 2023-05-02 | 2023-04-26 | 4 | Diamandis Peter | VAXX | Class A common stock | D | 1.2100 | 46,500 | 56 | 906,141 | ||||
| 2023-05-02 | 2023-04-26 | 4 | Diamandis Peter | VAXX | Class A common stock | D | 0.5700 | 429,037 | 245 | 859,641 | ||||
| 2023-04-28 | 3/A | Smith James Alan By IO Fund, LLC | VAXX | Class A common stock | I | 54,202 | ||||||||
| 2023-04-28 | 3/A | Smith James Alan | VAXX | Class A common stock | D | 8,058 | ||||||||
| 2023-02-10 | 3 | Smith James Alan | VAXX | Class A common stock | D | 8,058 | ||||||||
| 2023-02-10 | 3 | Smith James Alan By IO Fund, LLC | VAXX | Class A common stock | I | 12,268 | ||||||||
| 2023-02-10 | 3 | Ogilvie Landon E By child | VAXX | Class A common stock | I | 32,850 | ||||||||
| 2023-01-25 | 2023-01-23 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A common stock | D | 3.3514 | -405,217 | -1,358 | 8,764,372 | ||||
| 2023-01-25 | 2023-01-23 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A common stock | I | 3.3514 | -95,475 | -320 | 2,065,027 | ||||
| 2022-12-05 | 2022-12-02 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2.5682 | -11,121 | -29 | 9,169,589 | ||||
| 2022-12-05 | 2022-12-02 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2.5682 | -2,620 | -7 | 2,160,502 | ||||
| 2022-12-05 | 2022-12-01 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2.9717 | -270,964 | -805 | 9,180,710 | ||||
| 2022-12-05 | 2022-12-01 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2.9717 | -63,843 | -190 | 2,163,122 | ||||
| 2022-09-08 | 2022-09-06 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2.4029 | -25,243 | -61 | 9,451,674 | ||||
| 2022-09-08 | 2022-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2.4029 | -3,934 | -9 | 1,473,100 | ||||
| 2022-09-08 | 2022-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2.4029 | -2,234 | -5 | 836,499 | ||||
| 2022-09-08 | 2022-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2.4029 | -5,947 | -14 | 2,226,965 | ||||
| 2022-08-29 | 2022-08-22 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0.5700 | 2,640 | 2 | 68,645 | ||||
| 2022-08-29 | 2022-08-15 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0.5700 | 26,005 | 15 | 66,005 | ||||
| 2022-08-29 | 2022-07-29 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0.5700 | 20,000 | 11 | 40,000 | ||||
| 2022-08-29 | 2022-01-13 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0.5700 | 10,000 | 6 | 10,000 | ||||
| 2022-08-25 | 2022-08-25 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A common stock | D | 2.3310 | -22,757 | -53 | 9,476,917 | ||||
| 2022-08-25 | 2022-08-25 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A common stock | I | 2.3310 | -3,547 | -8 | 1,477,034 | ||||
| 2022-08-25 | 2022-08-25 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A common stock | I | 2.3310 | -2,014 | -5 | 838,733 | ||||
| 2022-08-25 | 2022-08-25 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A common stock | I | 2.3310 | -5,362 | -12 | 2,232,912 | ||||
| 2022-08-25 | 2022-08-24 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2.3862 | -83,786 | -200 | 9,499,674 | ||||
| 2022-08-25 | 2022-08-24 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2.3862 | -13,058 | -31 | 1,480,581 | ||||
| 2022-08-25 | 2022-08-24 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2.3862 | -7,415 | -18 | 840,747 | ||||
| 2022-08-25 | 2022-08-24 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2.3862 | -19,741 | -47 | 2,238,274 | ||||
| 2022-08-25 | 2022-08-23 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2.4466 | -33,785 | -83 | 9,583,460 | ||||
| 2022-08-25 | 2022-08-23 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2.4466 | -5,265 | -13 | 1,493,639 | ||||
| 2022-08-25 | 2022-08-23 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2.4466 | -2,990 | -7 | 848,162 | ||||
| 2022-08-25 | 2022-08-23 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2.4466 | -7,960 | -19 | 2,258,015 | ||||
| 2022-06-23 | 2021-11-18 | 4/A | Diamandis Peter | VAXX | Class A common stock | D | 13.0000 | -248 | -3 | 90,499 | ||||
| 2022-06-23 | 2021-11-15 | 4/A | Diamandis Peter | VAXX | Class A common stock | D | 13,824 | 13,824 | ||||||
| 2022-06-23 | 2021-11-15 | 4/A | Diamandis Peter Held by spouse | VAXX | Class A common stock | I | 13,824 | 13,824 | ||||||
| 2022-06-23 | 2022-01-24 | 4/A | Diamandis Peter | VAXX | Class A common stock | D | 8.6000 | -312,659 | -2,689 | 430,604 | ||||
| 2022-06-21 | 2022-06-16 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 1.9929 | 100,000 | 199 | 51,737,344 | ||||
| 2022-06-21 | 2022-06-16 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 1.9929 | 100,000 | 199 | 51,737,344 | ||||
| 2022-06-21 | 2022-06-16 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 1.9929 | 100,000 | 199 | 51,737,344 | ||||
| 2022-06-14 | 2022-06-13 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2.4259 | -92,569 | -225 | 9,617,245 | ||||
| 2022-06-14 | 2022-06-13 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2.4259 | -14,427 | -35 | 1,498,904 | ||||
| 2022-06-14 | 2022-06-13 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2.4259 | -8,193 | -20 | 851,152 | ||||
| 2022-06-14 | 2022-06-13 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2.4259 | -21,811 | -53 | 2,265,975 | ||||
| 2022-06-14 | 2022-06-10 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2.7981 | -28,378 | -79 | 9,709,814 | ||||
| 2022-06-14 | 2022-06-10 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2.7981 | -4,423 | -12 | 1,513,331 | ||||
| 2022-06-14 | 2022-06-10 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2.7981 | -2,512 | -7 | 859,345 | ||||
| 2022-06-14 | 2022-06-10 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2.7981 | -6,687 | -19 | 2,287,786 | ||||
| 2022-06-10 | 2022-06-09 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 2.7193 | 10,978 | 30 | 51,637,344 | ||||
| 2022-06-10 | 2022-06-08 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 2.9534 | 10,000 | 30 | 51,626,366 | ||||
| 2022-06-10 | 2022-06-09 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 2.7193 | 10,978 | 30 | 51,637,344 | ||||
| 2022-06-10 | 2022-06-08 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 2.9534 | 10,000 | 30 | 51,626,366 | ||||
| 2022-06-10 | 2022-06-09 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 2.7193 | 10,978 | 30 | 51,637,344 | ||||
| 2022-06-10 | 2022-06-08 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 2.9534 | 10,000 | 30 | 51,626,366 | ||||
| 2022-05-05 | 2022-05-03 | 4 | Guirakhoo Farshad | VAXX | Stock Option (right to buy) | D | 0.57 | -10,000 | 116,730 | |||||
| 2022-05-05 | 2022-05-03 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0.5700 | 10,000 | 6 | 10,000 | ||||
| 2022-04-28 | 2022-04-27 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3.5826 | 4,807 | 17 | 51,616,366 | ||||
| 2022-04-28 | 2022-04-26 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3.4503 | 18,105 | 62 | 51,611,559 | ||||
| 2022-04-28 | 2022-04-27 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3.5826 | 4,807 | 17 | 51,616,366 | ||||
| 2022-04-28 | 2022-04-26 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3.4503 | 18,105 | 62 | 51,611,559 | ||||
| 2022-04-28 | 2022-04-27 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 3.5826 | 4,807 | 17 | 51,616,366 | ||||
| 2022-04-28 | 2022-04-26 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 3.4503 | 18,105 | 62 | 51,611,559 | ||||
| 2022-04-27 | 2022-04-25 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3.3681 | 8,038 | 27 | 51,593,454 | ||||
| 2022-04-27 | 2022-04-25 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3.3681 | 8,038 | 27 | 51,593,454 | ||||
| 2022-04-27 | 2022-04-25 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 3.3681 | 8,038 | 27 | 5,193,454 | ||||
| 2022-04-04 | 2022-03-31 | 4 | Powchik Peter | VAXX | Stock Option (right to buy) | D | 4.30 | 94,186 | 94,186 | |||||
| 2022-04-04 | 3 | Powchik Peter | VAXX | Class A common stock | D | 225,858 | ||||||||
| 2022-03-15 | 2022-03-15 | 4 | Palm Ulo | VAXX | Restricted Stock Units | D | 100,000 | 100,000 | ||||||
| 2022-01-26 | 2022-01-24 | 4 | Diamandis Peter | VAXX | Stock Option (right to buy) | D | 4.12 | -652,764 | 163,191 | |||||
| 2022-01-26 | 2022-01-24 | 4 | Diamandis Peter | VAXX | Class A common stock | D | 4.1192 | 652,764 | 2,689 | 729,687 | ||||
| 2022-01-11 | 2022-01-03 | 4 | Pesile Jason | VAXX | Stock Option (right to buy) | D | 5.96 | 51,225 | 51,225 | |||||
| 2022-01-06 | 2021-12-31 | 4 | Chui James | VAXX | Class A common stock | D | 5.4800 | 6,000 | 33 | 14,000 | ||||
| 2022-01-05 | 2022-01-03 | 4 | HORNIG GEORGE R | VAXX | Stock Option (right to buy) | D | 5.96 | 67,953 | 67,953 | |||||
| 2021-12-14 | 2021-12-10 | 4 | Chui James | VAXX | Class A common stock | D | 7.8900 | 8,000 | 63 | 8,000 | ||||
| 2021-11-18 | 2021-11-16 | 4 | BLATT GREGORY R | VAXX | Class A common stock | D | 76,923 | 76,923 | ||||||
| 2021-11-18 | 2021-11-16 | 4 | BLATT GREGORY R Held by Bald Eagle IV LLC | VAXX | Class A common stock | I | -76,923 | 0 | ||||||
| 2021-11-18 | 2021-11-18 | 4 | Diamandis Peter | VAXX | Class A common stock | D | 76,923 | 76,923 | ||||||
| 2021-11-18 | 2021-11-18 | 4 | Diamandis Peter Held by Bald Eagle IV LLC | VAXX | Class A common stock | I | -76,923 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Diamandis Peter Held by spouse | VAXX | Series A preferred stock | I | -21,511 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Diamandis Peter Held by Bald Eagle IV LLC | VAXX | Class A common stock | I | 76,923 | 76,923 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Diamandis Peter Held by spouse | VAXX | Class A common stock | I | 271,655 | 271,655 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by The Gregory R. Blatt 2020 Annuity Trust III | VAXX | Series B preferred stock | I | -250,000 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by The Gregory R. Blatt 2020 Annuity Trust IX | VAXX | Series A preferred stock | I | -83,329 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by Blatt Family Investments LLC | VAXX | Series A preferred stock | I | -968,636 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by Bald Eagle IV LLC | VAXX | Class A common stock | I | 76,923 | 76,923 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by The Gregory R. Blatt 2020 Annuity Trust III | VAXX | Class A common stock | I | 160,668 | 160,668 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by The Gregory R. Blatt 2020 Annuity Trust IX | VAXX | Class A common stock | I | 53,553 | 53,553 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by Blatt Family Investments LLC | VAXX | Class A common stock | I | 622,516 | 622,516 | ||||||
| 2021-11-15 | 2021-11-11 | 4 | Guirakhoo Farshad | VAXX | Stock option (right to buy) | D | 13.00 | 41,958 | 41,958 | |||||
| 2021-11-15 | 2021-11-11 | 4 | Paula Molina Rene | VAXX | Stock option (right to buy) | D | 13.00 | 96,153 | 96,153 | |||||
| 2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by United Biomedical Inc., Asia | VAXX | Series A preferred stock | I | -6,554,643 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Series A preferred stock | I | -384,410 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by Blackfoot Healthcare Ventures LLC | VAXX | Series A preferred stock | I | -422,696 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by United Biomedical Inc., Asia | VAXX | Class A common stock | I | 4,212,495 | 4,212,495 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 247,050 | 51,585,416 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by Blackfoot Healthcare Ventures LLC | VAXX | Class A common stock | I | 271,655 | 271,655 | ||||||
| 2021-11-15 | 2021-11-12 | 4 | Reese Lou | VAXX | Class A common stock | D | 13.8240 | 17,500 | 242 | 17,500 | ||||
| 2021-11-15 | 2021-11-15 | 4 | Palm Ulo Held by spouse | VAXX | Class A common stock | I | 13.0000 | 450 | 6 | 450 | ||||
| 2021-11-15 | 2021-11-11 | 4 | Palm Ulo | VAXX | Stock option (right to buy) | D | 13.00 | 233,100 | 233,100 | |||||
| 2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by United Biomedical Inc., Asia | VAXX | Series A preferred stock | I | -6,554,643 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Series A preferred stock | I | -384,410 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by Blackfoot Healthcare Ventures LLC | VAXX | Series A preferred stock | I | -422,696 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by United Biomedical Inc., Asia | VAXX | Class A common stock | I | 4,212,495 | 4,212,495 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 247,050 | 51,585,416 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by Blackfoot Healthcare Ventures LLC | VAXX | Class A common stock | I | 271,655 | 271,655 | ||||||
| 2021-11-15 | 2021-11-12 | 4 | Hu Mei Mei Held by spouse | VAXX | Class A common stock | I | 13.8240 | 17,500 | 242 | 17,500 | ||||
| 2021-11-15 | 2021-11-15 | 4 | UNITED BIOMEDICAL INC Held by United Biomedical Inc., Asia | VAXX | Series A preferred stock | I | -6,554,643 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | UNITED BIOMEDICAL INC | VAXX | Series A preferred stock | D | -384,410 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | UNITED BIOMEDICAL INC Held by United Biomedical Inc., Asia | VAXX | Class A common stock | I | 4,212,495 | 4,212,495 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 247,050 | 51,585,416 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP | VAXX | Series A preferred stock | D | -15,152,627 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Series B preferred stock | I | -5,625,000 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Series A preferred stock | I | -2,361,626 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Series A preferred stock | I | -1,341,050 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Series A preferred stock | I | -3,570,201 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A common stock | D | 9,738,192 | 9,738,192 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Class A common stock | I | 3,615,038 | 3,615,038 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A common stock | I | 1,517,754 | 1,517,754 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A common stock | I | 861,857 | 861,857 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A common stock | I | 2,294,473 | 2,294,473 | ||||||
| 2021-11-10 | 3 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 51,338,366 | ||||||||
| 2021-11-10 | 3 | Doran Martin | VAXX | Class A common stock | D | 22,688 | ||||||||
| 2021-11-10 | 3 | Hu Mei Mei Held by United Biomedical Inc. See Note | VAXX | Class A common stock | I | 51,338,366 | ||||||||
| 2021-11-10 | 3 | Hu Mei Mei Held by spouse. See Note | VAXX | Class B common stock | I | 3,955,512 | ||||||||
| 2021-11-10 | 3 | Hu Mei Mei | VAXX | Class B common stock | D | 5,518,961 | ||||||||
| 2021-11-10 | 3 | Diamandis Peter | VAXX | Class B common stock | D | 1,099,915 | ||||||||
| 2021-11-10 | 3 | Reese Lou Held by spouse. See Note | VAXX | Class B common stock | I | 5,518,961 | ||||||||
| 2021-11-10 | 3 | Reese Lou | VAXX | Class B common stock | D | 3,955,511 | ||||||||
| 2021-11-10 | 3 | Reese Lou Held by United Biomedical Inc. See Note | VAXX | Class A common stock | I | 51,338,366 |
P
Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif
S
Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif
A
Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)
C
Penukaran derivatif
D
Penjualan atau pemindahan sekuriti kembali kepada syarikat
F
Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat
G
Hadiah sekuriti oleh atau kepada orang dalam
K
Swap ekuiti dan urus niaga lindung nilai yang serupa
M
Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)
V
Transaksi dilaporkan secara sukarela pada Borang 4
J
Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)
